Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-07-16
1977-04-05
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A11K 31495
Patent
active
040162737
ABSTRACT:
A sustained release depot form of the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]-oxazepine or 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f]-[1,4]oxazepine in an injectable oil for parenteral administration.
REFERENCES:
patent: 3164520 (1965-01-01), Huber
patent: 3538216 (1970-11-01), Polin
patent: 3546220 (1970-12-01), Schmutzet al.
patent: 3549621 (1970-12-01), Yole
patent: 3681357 (1972-08-01), Howell et al.
patent: 3773768 (1973-11-01), Howell et al.
patent: 3891647 (1975-06-01), Schmutz et al.
Martin - Remingtons's Pharmaceutical Sciences 13th Ed. pp. 627 and 634-636.
Krueger James Elwood
Osterberg Arnold Curtis
Sieger George Madison
Tedeschi David Henry
American Cyanamid Company
Friedman Stanley J.
Polyn Denis A.
LandOfFree
Sustained release forms of certain oxazepines for parenteral adm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release forms of certain oxazepines for parenteral adm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release forms of certain oxazepines for parenteral adm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2266297